Fig. 4From: Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in SpainPer-patient average relapse cost by type of relapse and treatment line, and accumulative. Pax: patients; 1L: first-line; 2L: second-line; 3L: third-line; 4L; forth-lineBack to article page